1. Home
  2. PRAA vs AURA Comparison

PRAA vs AURA Comparison

Compare PRAA & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PRA Group Inc.

PRAA

PRA Group Inc.

HOLD

Current Price

$18.49

Market Cap

639.1M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.84

Market Cap

713.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAA
AURA
Founded
1996
2007
Country
United States
United States
Employees
170
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
639.1M
713.4M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
PRAA
AURA
Price
$18.49
$6.84
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$24.50
$20.00
AVG Volume (30 Days)
897.1K
749.6K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.73
N/A
Revenue
$1,201,837,000.00
N/A
Revenue This Year
$2.01
N/A
Revenue Next Year
$2.53
N/A
P/E Ratio
$25.03
N/A
Revenue Growth
7.83
N/A
52 Week Low
$10.25
$4.73
52 Week High
$22.55
$9.54

Technical Indicators

Market Signals
Indicator
PRAA
AURA
Relative Strength Index (RSI) 59.78 47.57
Support Level $16.60 $6.34
Resistance Level $19.29 $7.04
Average True Range (ATR) 0.89 0.56
MACD 0.08 0.03
Stochastic Oscillator 79.59 28.08

Price Performance

Historical Comparison
PRAA
AURA

About PRAA PRA Group Inc.

PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: